Technology | April 08, 2013

First new software aims to better Aplio 500 and 300

To expand imaging capabilities and improve productivity, Toshiba America Medical Systems, Inc. introduces Innovation 2013, new FDA-cleared software advancements for the Aplio 500 and Aplio 300 ultrasound systems.


April 8, 2013 — Toshiba America Medical Systems, Inc. has introduced Innovation 2013, new U.S. Food and Drug Administration (FDA)-cleared software advancements for the Aplio 500 and Aplio 300 ultrasound systems.

Innovation 2013 offers the latest enhancements in ultrasound imaging, including B-Mode and Color Doppler, with additional features as options:

• Luminance: A 4-D rendering and lighting technique producing stellar fetal images, Luminance can better visualize the fetal face and other anatomical structures by applying color and illumination to enhance features.

• New transducers: The PVT-781VT (3–11 MHz) is a high-resolution, endocavitary transducer designed for producing superb endovaginal and prostate imaging. This transducer supports the Aplio 500’s Smart Fusion technology, which synchronizes computed tomography (CT) or magnetic resonance (MR) with ultrasound images on a single screen. The PLT-1005BT (5–14 MHz) is a high-frequency, high-resolution linear array transducer ideal for small-parts imaging, including breast. This transducer has a wide aperture of 58 millimeters.

• Workflow enhancements: Next-generation Quick Assist Protocols, designed to automate workflow, increase consistency and standardize exams, allow for greater focus on the patient.

All existing Aplio 500 and 300 customers will receive the Innovation 2013 software upgrade complimentary, excluding new options.

The systems also offer:

• Fly Thru: An industry first, Fly Thru uses 4-D ultrasound to “fly through” interiors of fluid-filled ducts and vessels for better exploration of lesions and masses, and to assist in planning interventional procedures.

• Smart Fusion: Combines the best in imaging by synchronizing CT or MR with ultrasound to locate hard-to-find lesions and aid in ultrasound-guided biopsies.

“Aplio 500 and 300 offer advanced visualization capabilities and enhanced ergonomics for more accurate diagnoses and faster patient exams,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba.

For more information: www.medical.toshiba.com


Related Content

News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
Feature | Women's Health | By Jordan Bazinsky

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
News | Ultrasound Women's Health

June 18, 2024 — The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) has announced details of ...

Time June 18, 2024
arrow
News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo ...

Time May 20, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

April 24, 2024 — The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) announced an ...

Time April 24, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Radiation Oncology

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
Subscribe Now